Drug intelligence / Profile preview

lidocaine + vasopressin + sodium bicarbonate

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous, Intraosseous
01

Overview

This is a combination of three drugs—lidocaine, vasopressin, and sodium bicarbonate—used primarily in emergency and critical care settings. Each component has a distinct mechanism of action: - **Lidocaine** is a local anesthetic and class Ib antiarrhythmic agent that works by blocking voltage-gated sodium channels (specifically the sodium channel protein type 1 subunit alpha), thereby inhibiting nerve signal transmission and stabilizing cardiac membranes to treat arrhythmias[2][1]. - **Vasopressin** is an endogenous hormone with vasoconstrictive properties; it acts on V1 receptors in vascular smooth muscle to increase peripheral vascular resistance and blood pressure, often used as a vasopressor during cardiac arrest or shock states[4]. - **Sodium bicarbonate** is an alkalinizing agent that buffers excess hydrogen ions, raising blood pH. It is used to correct metabolic acidosis, treat certain drug overdoses (such as tricyclic antidepressant toxicity), hyperkalemia, or prolonged cardiac arrest[4][7][8]. This combination may be considered in advanced resuscitation protocols for specific indications such as refractory ventricular arrhythmias (lidocaine), severe hypotension unresponsive to fluids (vasopressin), or metabolic derangements/acidosis (sodium bicarbonate). The mixture itself does not have a unique brand name but represents concurrent administration of these agents according to clinical need.

02

Targets

AVPR1A (Arginine vasopressin receptor 1A)SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)

Beyond the preview

Go deeper on lidocaine + vasopressin + sodium bicarbonate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + vasopressin + sodium bicarbonate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call